JPMorgan Downgrades Clorox to Underweight Amid Rising Competition and Costs

JPMorgan has downgraded The Clorox Company (CLX) from Neutral to Underweight, signaling a cautious outlook on the consumer goods giant. Analyst Andrea Teixeira specified that the company faces below-trend category growth, exacerbated by intensifying competition from private label brands. Analysts further highlighted that a stretched consumer base, facing increased financial pressure, is a key driver behind the bearish sentiment. Despite the downgrade, Clorox management continues to successfully execute its digital transformation and innovation strategies. However, rising operational costs continue to weigh on profit margins ahead of the company's third-quarter earnings report on April 30, 2026. The stock experienced downward pressure as investors weigh the company's technological progress against broader structural and macroeconomic headwinds.